Digital Twin Generators for Disease Modeling
Authors:
Nameyeh Alam,
Jake Basilico,
Daniele Bertolini,
Satish Casie Chetty,
Heather D'Angelo,
Ryan Douglas,
Charles K. Fisher,
Franklin Fuller,
Melissa Gomes,
Rishabh Gupta,
Alex Lang,
Anton Loukianov,
Rachel Mak-McCully,
Cary Murray,
Hanalei Pham,
Susanna Qiao,
Elena Ryapolova-Webb,
Aaron Smith,
Dimitri Theoharatos,
Anil Tolwani,
Eric W. Tramel,
Anna Vidovszky,
Judy Viduya,
Jonathan R. Walsh
Abstract:
A patient's digital twin is a computational model that describes the evolution of their health over time. Digital twins have the potential to revolutionize medicine by enabling individual-level computer simulations of human health, which can be used to conduct more efficient clinical trials or to recommend personalized treatment options. Due to the overwhelming complexity of human biology, machine…
▽ More
A patient's digital twin is a computational model that describes the evolution of their health over time. Digital twins have the potential to revolutionize medicine by enabling individual-level computer simulations of human health, which can be used to conduct more efficient clinical trials or to recommend personalized treatment options. Due to the overwhelming complexity of human biology, machine learning approaches that leverage large datasets of historical patients' longitudinal health records to generate patients' digital twins are more tractable than potential mechanistic models. In this manuscript, we describe a neural network architecture that can learn conditional generative models of clinical trajectories, which we call Digital Twin Generators (DTGs), that can create digital twins of individual patients. We show that the same neural network architecture can be trained to generate accurate digital twins for patients across 13 different indications simply by changing the training set and tuning hyperparameters. By introducing a general purpose architecture, we aim to unlock the ability to scale machine learning approaches to larger datasets and across more indications so that a digital twin could be created for any patient in the world.
△ Less
Submitted 2 May, 2024;
originally announced May 2024.
A Weighted Prognostic Covariate Adjustment Method for Efficient and Powerful Treatment Effect Inferences in Randomized Controlled Trials
Authors:
Alyssa M. Vanderbeek,
Anna A. Vidovszky,
Jessica L. Ross,
Arman Sabbaghi,
Jonathan R. Walsh,
Charles K. Fisher,
the Critical Path for Alzheimer's Disease,
the Alzheimer's Disease Neuroimaging Initiative,
the European Prevention of Alzheimer's Disease,
Consortium,
the Alzheimer's Disease Cooperative Study
Abstract:
A crucial task for a randomized controlled trial (RCT) is to specify a statistical method that can yield an efficient estimator and powerful test for the treatment effect. A novel and effective strategy to obtain efficient and powerful treatment effect inferences is to incorporate predictions from generative artificial intelligence (AI) algorithms into covariate adjustment for the regression analy…
▽ More
A crucial task for a randomized controlled trial (RCT) is to specify a statistical method that can yield an efficient estimator and powerful test for the treatment effect. A novel and effective strategy to obtain efficient and powerful treatment effect inferences is to incorporate predictions from generative artificial intelligence (AI) algorithms into covariate adjustment for the regression analysis of a RCT. Training a generative AI algorithm on historical control data enables one to construct a digital twin generator (DTG) for RCT participants, which utilizes a participant's baseline covariates to generate a probability distribution for their potential control outcome. Summaries of the probability distribution from the DTG are highly predictive of the trial outcome, and adjusting for these features via regression can thus improve the quality of treatment effect inferences, while satisfying regulatory guidelines on statistical analyses, for a RCT. However, a critical assumption in this strategy is homoskedasticity, or constant variance of the outcome conditional on the covariates. In the case of heteroskedasticity, existing covariate adjustment methods yield inefficient estimators and underpowered tests. We propose to address heteroskedasticity via a weighted prognostic covariate adjustment methodology (Weighted PROCOVA) that adjusts for both the mean and variance of the regression model using information obtained from the DTG. We prove that our method yields unbiased treatment effect estimators, and demonstrate via comprehensive simulation studies and case studies from Alzheimer's disease that it can reduce the variance of the treatment effect estimator, maintain the Type I error rate, and increase the power of the test for the treatment effect from 80% to 85%~90% when the variances from the DTG can explain 5%~10% of the variation in the RCT participants' outcomes.
△ Less
Submitted 25 September, 2023;
originally announced September 2023.
